18 and older, any sex, with Trust or Chronic Low Back Pain. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change in Patient Care Assessment SurveyPrimary· through study completion, an average of 1 year
Measurement of trust of patient toward provider during clinical encounter. Minimum score of 8, maximal score of 40. Questions 1-7 are scored with a 5-point Likert scale, Question 8 is scored with a 11-point Likert scale. Higher score indicate better levels of trust.
Group
Value
95% CI
Patient Participants
3.3
± 1.1
Change in Wake Forest ScalePrimary· through study completion, an average of 1 year
Measurement of trust of patient toward provider during clinical encounter. 10 item scale using a 5-point Likert scale. Score range from 10-50, with higher score indicating higher levels of trust.
Group
Value
95% CI
Patient Participants
4.2
± 1.5
Change in Trust in Physician ScalePrimary· through study completion, an average of 1 year
Measurement of trust of patient toward provider during clinical encounter. 11 item scale using 5-point Likert scale. Score range from 11-55, with higher score indicating higher levels of trust.
Group
Value
95% CI
Patient Participants
5.2
± .5
Change in Oswestry Disability Index 2.0Primary· through study completion, an average of 1 year
Measurement of function for individuals with low back pain. 10 categories with 6 statements scoring (0-5) for function. Raw scores range from 0-50, they are divided by highest possible score to produce a percentage. Lower percentage demonstrates less disability.
Group
Value
95% CI
Patient Participants
11.1
± 17.7
Change in Numeric Pain Rating ScalePrimary· through study completion, an average of 1 year
Pain measurement scale. Measurement on 11-point scale from 0= no pain to 10= worst pain imaginable. Measure current, best in last 24 hours, and worst in last 24 hours and take average of all 3 measurements. Lower score represents lower pain rating.
Group
Value
95% CI
Patient Participants
1.1
± 2.6
Global Rate of ChangePrimary· through study completion, an average of 1 year
Global measurement of change of status during care. 11-point scale used (-5=very much worse, 0 = unchanged, 5 = completely recovered). Higher score represents better recovery.
Group
Value
95% CI
Patient Participants
2.3
± .5
General Trust in Physician ScaleSecondary· through study completion, an average of 1 year
global trust measurement of patient, 11 item scale using 5 point Likert scale. Minimum score 11, maximum score 55. Higher values, higher levels of trust. No subscales.
Group
Value
95% CI
Patient Participants
43.89
± 6.27
Change in Working Alliance Inventory - Short RevisedSecondary· after initial visit and discontinuation of services, an average of 4-8 weeks.
therapeutic alliance measurement. 12 item short form utilizing 5 point Likert scale. minimum score 12, maximum score 60. Higher score means higher therapeutic (working) alliance.
Group
Value
95% CI
Patient Participants
5.6
± 2.3
Change in PT Survey of Patient Connection and EngagementSecondary· after 2nd visit and discontinuation of services, an average of 4-8 weeks.
Questionnaire completed by PT regarding their perceptions of the patients connection and engagement during the course of care. 10 question survey, using 5 point Likert scale. minimum score 10, maximum score 50. Higher score demonstrates higher patient connection and engagement.
Group
Value
95% CI
Patient Participants
0
± .5
Sponsor's own description
To investigate whether changes in trust between physical therapist and patient correlate to outcomes after receiving physical therapy care. We will be utilizing established questionnaires from the medical literature and one new generated questionnaire.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of South Dakota
Last refreshed: 15 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03443401.